SCHEMBL3432876

SCHEMBL3432876

O=C1CCN(c2nc(Nc3cc(C4CC4)n[nH]3)n3cccc3n2)N1

nearest known ligand 0.32

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.32
G6PD P11413 1/20 0.30
ALOX15 P16050 1/20 0.30
ALOX12 P18054 1/20 0.30
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
DRD2 P14416 2/20 0.30
DRD4 P21917 2/20 0.30
DRD3 P35462 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL916585 0.83
SCHEMBL916719 0.81 POLB (0.36)
SCHEMBL3923615 0.80 PAK1 (0.40)
SCHEMBL915798 0.78 DRD2 (0.36) DRD2DRD4DRD3
SCHEMBL3932218 0.77 DKK1 (0.36) DRD2DRD4DRD3
SCHEMBL3928070 0.77 ROCK2 (0.37) DRD2DRD4DRD3
SCHEMBL10292716 0.77 IGF1R (0.44)
SCHEMBL3923740 0.76 SMO (0.40)
SCHEMBL3926065 0.76 PIK3CB (0.36)
SCHEMBL1268788 0.74 IGF1R (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262806-A1 PYRROLOTRIAZINE KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2010-12-22 EP disclosed
WO-2009111531-A1 PYRROLOTRIAZINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-11 WO disclosed